Journal article

Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

AM Cornall, M Poljak, SM Garland, S Phillips, JH Tan, DA Machalek, MA Quinn, SN Tabrizi

European Journal of Clinical Microbiology and Infectious Diseases | SPRINGER | Published : 2017

Abstract

Purpose: to evaluate the performance of Anyplex II HPV28 and HPV HR Detection assays against the EuroArray HPV, Cobas 4800 HPV (Cobas), HPV Amplicor (Amp), Linear Array HPV (LA) and Hybrid Capture 2 (HC2) in detection of high-risk HPV (HR-HPV) from liquid-based cervical cytology samples. Methods: cervical specimens from 404 women undergoing management of high-grade cytological abnormality were evaluated by Anyplex II HPV28 and HPV HR Detection assays for detection of HR-HPV genotypes and prediction of histologically-confirmed cervical intraepithelial neoplasia grade 2 or higher (≥CIN2). The results were compared to EuroArray, HC2, Cobas, Amp, and LA. Results: specimens were evaluated from 40..

View full abstract

University of Melbourne Researchers

Grants

Funding Acknowledgements

Seegene Inc. supplied the detection kits required for this study. Seegene did not contribute to the design of the study, interpretation of results, or preparation of the manuscript. A member of the Seegene academic team was given the opportunity to comment on technical accuracy of the manuscript related to use of the assay.